1. Ng, K. M., Aranda-Díaz, A., Tropini, C., Frankel, M. R., Van Treuren, W., O'Laughlin, C. T., Merrill, B. D., Yu, F. B., Pruss, K. M., Oliveira, R. A., Higginbottom, S. K., Mark Welch, J. L., Haiser, H. J., Turnbaugh, P. J., Sonnenburg, J. L., Xavier, R. J., & Sonnenburg, E. D. (2019). Recovery of the gut microbiota after antibiotics depends on host diet, community context, and environmental reservoirs. Cell Host & Microbe, 26(5), 650-665.e4.
2. Hempel, S., Newberry, S. J., Maher, A. R., Wang, Z., Miles, J. N., Shanman, R., Johnsen, B., & Shekelle, P. G. (2012). Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA, 307(18), 1959-1969.

A- Lahiri K et al. Bacillus clausii As An Adjuvant Therapy In Acute Childhood Diarrhoea. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2015;14:74-76.

B- Giua et al (2024). A Prospective Real-World Study of Bacillus clausii Evaluating Use, Treatment Habits and Patient Satisfaction in Italian Community Pharmacies: The PEGASO Study. Drugs - Real World Outcomes (2024) 11:137–147.

C- Ghelardi et al (2015). Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. Journal of Applied Microbiology 119, 552-559.

D- Castro et al (2019). Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE). Tropical Diseases, Travel Medicine and Vaccines 5:14.